Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's Disease (F-IBDQ)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of the study is to develop a validated French version of the IBDQ in a cohort of patients suffering from Inflammatory bowel diseases, namely Crohn's disease and Ulcerative Colitis.
Condition or disease
Ulcerative ColitisCrohn's Disease
Other: Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ)
Importance of measuring subjective aspects of the patient's health, often referred to as quality of life (QoL), become increasingly recognized and integrated into healthcare. For this purpose, The Inflammatory Bowel Disease Questionnaire (IBDQ) is a widely used questionnaire for QoL assessment specific for patients who suffer from inflammatory bowel diseases. However, the IBDQ was originally developed in a cohort of Canadian patients in English language. Since QoL is impacted by underlying cultural trends, any translation of the IBDQ should be reassessed in relation to its validity, reliability, and sensitivity to detect change in the new language and cultural context. While the linguistic French translation of the original IBDQ has been validated, the French IBDQ has never been tested adequately on a French cohort of patient that we aim to perform.
Internal validity, scale F-IBDQ [ Time Frame: Day1 and Month4 ]
Chronbach's alpha coefficient, measured at the first visit and at the second visit.
External validity, questionnaire SF36 [ Time Frame: Day1 and Month4 ]
Correlation with the French validated SF-36 and disease activity indexes (Harvey Bradshaw index for Crohn's disease and Simple Colitis Activity Index for ulcerative colitis, measured at the first visit and at the second visit.
Discriminant ability, disease activity indexes [ Time Frame: Day1 and Month4 ]
Correlation with disease activity indexes, measured at the first visit and at the second visit.
Reliability, disease outcomes [ Time Frame: Day1 and Month4 ]
Correlation with disease outcomes, measured at the first visit and at the second visit.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patient with definite diagnosis of UC or CD for at least 6 months
men and women ≥ 18 years of age,
patient with definite diagnosis of UC or CD for at least 6 months
adults legally protected (under judicial protection, guardianship, or supervision), persons deprived of their liberty
inability to comprehend or complete the self-administered questionnaire
psychiatric diagnosis that prevents participation (many pts will have anxiety or depression and should not be excluded)